Medico-economic Evaluation of Management Strategies for Severe Epistaxis — EPICOST  

Epistaxis Clinical Trial

Official title: Medico-economic Evaluation of Management Strategies for Severe Epistaxis

Status Recruiting

Clinical Trial Summary

Current recommendations consider surgical ligation and supra-selective embolization as equivalent in terms of efficacy and there is no clear consensus to choose between one and the other technique. In the absence of medico-economic studies, these recommendations could not be based on any differences in efficiency between the two techniques. The management of patients with severe non-traumatic epistaxis remains controversial and varies according to the hospital and/or university centers. In practice, the use of one or the other technique depends on the habits of each reference center.

Clinical Trial Description

The hypothesis is that early ligation of the sphenopalatine arteries would reduce the costs of care for the community while improving the quality of life of patients compared to supra-elective embolization.

This medico-economic superiority could go through:

• reduction in the number of recurrences

• reduction in the length of hospital stays.

• reduction in the cost of postoperative care.

• reduction of iatrogenic complications

• improvement of functional suites upon return home.

• Tertiary prevention of dependency, particularly among the elderly ;

Related Conditions & MeSH terms

• Epistaxis

• NCT number: NCT05281952
• Study type: Interventional
• Source: University Hospital, Toulouse
• Contact: Guillaume DE BONNECAZE, MD
• Phone: 0567771641
• Email: debonnecaze.g@chu-toulouse.fr
• Status: Recruiting
• Phase: N/A
• Start date: May 1, 2023
• Completion date: December 2026